ArticleCancer reports (Hoboken, N.J.)2022

Role of eIF4A1 in triple-negative breast cancer stem-like cell-mediated drug resistance.

Dayanidhi Raman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.